Read about upcoming changes to UnitedHealthcare coverage.
At Weill Cornell Medicine, the Peritoneal Surface Malignancy Program provides advanced, multidisciplinary care for patients with cancers that spread to the lining of the abdomen (the peritoneum). Our team specializes in diagnosing, treating, and supporting patients with rare and complex conditions, offering the latest treatment options, including cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Our program at Weill Cornell Medicine focuses on a wide range of peritoneal surface cancers and related conditions, including:
Because these cancers behave differently than tumors in other organs, they require a highly specialized team with deep experience in both surgical and nonsurgical approaches.
At Weill Cornell Medicine, every patient receives coordinated care from an expert group that may include:
This collaborative approach ensures seamless, comprehensive care from diagnosis through survivorship.
This complex procedure removes visible tumors from the abdominal cavity. Our surgeons are highly experienced in performing extensive CRS procedures while prioritizing patient safety and long-term outcomes.
Following CRS, heated chemotherapy is circulated directly in the abdomen to target microscopic cancer cells. HIPEC allows for high‑dose, localized treatment with fewer systemic side effects.
At Weill Cornell Medicine, we tailor each plan to the patient’s cancer type, stage, and overall health.
Our surgical team at Weill Cornell Medicine performs a high volume of CRS/HIPEC procedures each year—an important factor linked to improved outcomes and patient safety.
From nutritional optimization to rehab and emotional support, we guide patients through every stage of their journey.
Our team at Weill Cornell Medicine participates in ongoing research to advance the treatment of peritoneal surface malignancies and offer eligible patients access to clinical trials focused on novel therapies.
We understand that living with cancer affects every aspect of life. Our program is designed to support patients medically, emotionally, and practically.
During your initial consultation, you will meet with members of our multidisciplinary care team to:
We encourage patients to bring family members or caregivers to support the discussion and decision‑making process.
To help you and your loved ones throughout treatment, we offer:
Our team is here to help you navigate your diagnosis and find the best path forward. Whether you visit us virtually through a video visit or you see us in person, you can be assured that we will deliver the highest standards of care with compassion. To make an appointment, please call (646) 962-2270 or complete our online appointment request form.
If you would like a remote second opinion, we can connect you directly with expert physicians and specialists at the Weill Cornell Medicine Colon and Rectal Surgery Division. They will review your individual situation, answer your questions and provide you with information you can share with your family and local practitioner. You can then decide to come to our facilities for treatment or choose to stay in your hometown and receive treatment locally. Learn more at WCM OnDemand Second Opinion.
The physicians at the Weill Cornell Medicine’s Peritoneal Surface Malignancy Program offers patients the highest level of safety and care. As a top-ranked academic medical center, you have access to our extensive network of specialists who provide seamless care throughout your treatment — to promote long-term physical and mental health.
